fbpx

Parkinson’s Disease

141 results.

December 7, 2016 Diabetes drug slows experimental Parkinson’s disease progression, human trials to begin next year

New data published today shows drug preserves critical brain function in laboratory models of Parkinson’s GRAND RAPIDS, Mich. (Dec. 7, 2016)—A new investigational drug originally…

November 4, 2016 MSU and VARI investigators working toward slowing progression of Parkinson's

A few years ago, Caryl Sortwell, a Michigan State University College of Human Medicine Parkinson's researcher, was asked by Jeff MacKeigan, a…

VAI DEFAULT HEADER
September 8, 2016 Diabetes drug focus of new clinical trial for Parkinson’s disease

HIGHLIGHTS A clinical trial is now underway at Cedars-Sinai in Los Angeles to test the efficacy and safety of a type II diabetes drug as…

VAI DEFAULT HEADER
August 8, 2016 New model recreates early spread of Parkinson’s disease in the brain

GRAND RAPIDS, Mich. (Aug. 8, 2016)—They’re two of the biggest mysteries in Parkinson’s disease research—where does the disease start? And how can it be stopped…

July 27, 2016 Indicators of Parkinson’s disease risk found in unexpected places

GRAND RAPIDS, Mich. (July 27, 2016)—Clues that point toward new risk mechanisms for developing Parkinson’s disease are hiding in some unusual spots, according to

VAI DEFAULT HEADER
July 12, 2016 Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease

Note: To read the commentary published in the Journal of Parkinson's Disease click here. Investigators will focus on safety for long-term use in non-cancer…

June 14, 2016 Lessons from lactose intolerance: Investigating epigenomic aging

New insights into lactose intolerance may give scientists more than a better understanding of why some people lose the ability to digest…

May 24, 2016 Explaining the epigenome: An interview with Dr. Viviane Labrie (part two)

Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the…